Weight Loss & Cardiovascular Risk in Type 2 Diabetes Study
Active, not recruiting
- Conditions
- Type 2 diabetesObesityMetabolic and Endocrine - DiabetesDiet and Nutrition - Obesity
- Registration Number
- ACTRN12606000107527
- Lead Sponsor
- CSIRO & Diabetes Aust research trust
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Active, not recruiting
- Sex
- All
- Target Recruitment
- 40
Inclusion Criteria
BMI greater than 27, less than 40Type 2 diabetes.
Exclusion Criteria
Beta-blocker or glucocortcoids medicationdietary supplementsregular physcial exercise.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 1. Endothelial function (flow mediated dilatation)[Measured at week 0 (baseline) and week 12 (end of intervention).];2. Cardiovascular disease risk markers[Measured at week 0 (baseline) and week 12 (end of intervention).]
- Secondary Outcome Measures
Name Time Method